CF Clinical Update
Promising early stage clinical trial results for three next-generation CFTR modulator therapies that target the underlying defect in cystic fibrosis were announced. The studies, led by Vertex Pharmaceuticals Inc., highlight
Run for Roses – Presented by the Rose Foundation | Category Archives: CF Update